Biovica International AB (publ)
SSE:BIOVIC-B.ST
Overview | Financials
Company Name | Biovica International AB (publ) |
Symbol | BIOVIC-B.ST |
Currency | SEK |
Price | 2.34 |
Market Cap | 182,015,262 |
Dividend Yield | 0% |
52-week-range | 2.205 - 10.36 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Anders Rylander |
Website | https://www.biovica.com |
An error occurred while fetching data.
About Biovica International AB (publ)
Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD